Hjem › Glioblastom › Arizona
Kliniske studier for Glioblastom i Arizona
13 studier for Glioblastom søker deltakere på steder i Arizona.
Byer i Arizona
Offisiell studietekst (engelsk)
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Mayo Clinic Arizona, Phoenix
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05902169Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- HonorHealth Scottsdale Osborn Medical Center, Scottsdale
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07195591Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- Mayo Clinic Hospital in Arizona, Phoenix
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05432804Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Cancer Center at UMC North/University Medical Center, Tucson
RekruttererFase 1/2
Alder 18 til 99 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06814496SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Mayo Clinic - Arizona, Phoenix
- St. Joseph's Hospital and Medical Center, Phoenix
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05303519BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
- St. Joseph's Hospital and Medical Center, Phoenix
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07485049Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
- Mayo Clinic in Arizona, Phoenix
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07091864Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Honor Health, Scottsdale
Rekrutterer
Alder 18 til 85 · Alle kjønn · Oppdatert 21. jul. 2026 · NCT06910306A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
- Mayo Clinic Hospital, Phoenix
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. apr. 2026 · NCT07185880Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Scottsdale, Scottsdale
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06810544A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
- St. Joseph's Hospital and Medical Center, Phoenix
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mar. 2026 · NCT07268053A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
- Chandler Regional Medical Center, Chandler
- St. Joseph's Hospital and Medical Center, Phoenix
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 20. nov. 2025 · NCT06072586SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.